Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E D Williamson

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Vaccine|October 20, 2009
PlagueE D Williamson
Clinical and Experimental Immunology|April 18, 2019
Vaccines for emerging pathogens: from research to the clinicE D Williamson
Journal of Applied Microbiology|September 29, 2001
Plague vaccine research and developmentE D Williamson
Advances in Preventive Medicine|October 13, 2011
The role of immune correlates and surrogate markers in the development of vaccines and immunotherapies for plagueE D Williamson
Clinical and Experimental Immunology|October 19, 2019
Vaccines for emerging pathogens: from research to the clinic. Part twoE D Williamson
Vaccine|September 1, 1993
A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangreneE D Williamson, R W Titball
Current Drug Targets. Infectious Disorders|October 8, 2003
Vaccine development for potential bioterrorism agentsR W Titball, E D Williamson
Vaccine|July 18, 2001
Vaccination against bubonic and pneumonic plagueR W Titball, E D Williamson
British Medical Bulletin|August 15, 2002
Vaccines against dangerous pathogensE D Williamson, R W Titball
Microbial Pathogenesis|September 20, 2000
The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responsesS J Elvin, E D Williamson
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Vaccine|October 20, 2009
PlagueE D Williamson
Clinical and Experimental Immunology|April 18, 2019
Vaccines for emerging pathogens: from research to the clinicE D Williamson
Journal of Applied Microbiology|September 29, 2001
Plague vaccine research and developmentE D Williamson
Advances in Preventive Medicine|October 13, 2011
The role of immune correlates and surrogate markers in the development of vaccines and immunotherapies for plagueE D Williamson
Clinical and Experimental Immunology|October 19, 2019
Vaccines for emerging pathogens: from research to the clinic. Part twoE D Williamson
Vaccine|September 1, 1993
A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangreneE D Williamson, R W Titball
Current Drug Targets. Infectious Disorders|October 8, 2003
Vaccine development for potential bioterrorism agentsR W Titball, E D Williamson
Vaccine|July 18, 2001
Vaccination against bubonic and pneumonic plagueR W Titball, E D Williamson
British Medical Bulletin|August 15, 2002
Vaccines against dangerous pathogensE D Williamson, R W Titball
Microbial Pathogenesis|September 20, 2000
The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responsesS J Elvin, E D Williamson
Pageof 8